title: Rituximab and rapamycin for posttransplant lymphoproliferative disease treatment: report of three cases.
authors.affiliation: Fundação Faculdade Federal de Ciências Médicas and Santa Casa Hospital, Porto Alegre, Brazil.
authors.forename: V D
authors.initials: VD
authors.lastname: Garcia
authors.forename: J S
authors.initials: JS
authors.lastname: Bonamigo-Filho
authors.forename: J
authors.initials: J
authors.lastname: Neumann
authors.forename: L
authors.initials: L
authors.lastname: Fogliatto
authors.forename: A M
authors.initials: AM
authors.lastname: Gaiger
authors.forename: C D
authors.initials: CD
authors.lastname: Garcia
authors.forename: V
authors.initials: V
authors.lastname: Barros
authors.forename: E
authors.initials: E
authors.lastname: Keitel
authors.forename: A E
authors.initials: AE
authors.lastname: Bittar
authors.forename: A F
authors.initials: AF
authors.lastname: Santos
authors.forename: S
authors.initials: S
authors.lastname: Roithmann
mesh_terms: D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy*; D008297:Male; D011183:Postoperative Complications / Q000188:drug therapy*; D000069283:Rituximab; D020123:Sirolimus / Q000627:therapeutic use*
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab; D020123:Sirolimus